Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · IEX Real-Time Price · USD
13.03
+0.03 (0.23%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Takeda Pharmaceutical Market Cap
Takeda Pharmaceutical has a market cap or net worth of $40.89 billion as of July 2, 2024. Its market cap has decreased by -16.60% in one year.
Market Cap
40.89B
Enterprise Value
73.11B
1-Year Change
-16.60%
Ranking
Category
Stock Price
$13.03
Market Cap Chart
Since January 5, 2010, Takeda Pharmaceutical's market cap has decreased from $71.21B to $40.89B, a decrease of -42.58%. That is a compound annual growth rate of -3.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 40.89B | -8.68% |
| Dec 29, 2023 | 44.78B | -7.43% |
| Dec 30, 2022 | 48.37B | 13.50% |
| Dec 31, 2021 | 42.62B | -24.84% |
| Dec 31, 2020 | 56.70B | -8.18% |
| Dec 31, 2019 | 61.76B | 134.31% |
| Dec 31, 2018 | 26.36B | -59.21% |
| Dec 30, 2016 | 64.61B | -22.54% |
| Dec 31, 2015 | 83.40B | 20.68% |
| Dec 31, 2014 | 69.11B | -9.90% |
| Dec 31, 2013 | 76.71B | 3.69% |
| Dec 31, 2012 | 73.97B | 0.68% |
| Dec 30, 2011 | 73.47B | -9.45% |
| Dec 31, 2010 | 81.14B | 13.94% |
| Jan 5, 2010 | 71.21B | - |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moderna | 45.51B |
| DexCom | 45.09B |
| Humana | 45.03B |
| Cencora | 44.94B |
| Alcon | 43.94B |
| IDEXX Laboratories | 40.24B |
| IQVIA Holdings | 38.52B |
| Agilent Technologies | 37.82B |